Breast Cancer in Mosul: A Survival Analysis

  • Taha HT Al-Saigh * Ninevaha College of Medicine, University of Ninevah, Mosul
  • Shahbaa A Al-bayati * Ninevaha College of Medicine, University of Ninevah, Mosul
  • Shatha A Abdul-mawjood * Ninevaha College of Medicine, University of Ninevah, Mosul
  • Faris A Ahmed College of Pharmacy, University of Uruk, Baghdad, Iraq


Breast cancer is the most common cancer in women, and the major cause of death. This study was conducted in order to make a descriptive study and survival analysis for breast cancer patients in Mosul. Two hundred forty-six early diagnosed women with breast cancer out of 290 patients were included during the period from March 2007 to February 2012. The average follows up was 36.

months (range: 11-67 months). The patients were undergone modified radical removal of the breast, chemotherapy and deep radiation. Patients with estrogen positive were given tamoxifen for five years. Patients with Her2/neu positive were given trastuzumab with docytaxil for one year. Only 25 patients (10.2%) died during the study. The highest incidence of breast cancer (35.8%) was between the ages 51 ≥ 60 years. The presentation of cancer was high (90.1%) in the lumber. Tumor in the right side (66.35%) was significantly higher than the left side. Metastasis was high (25%) and most of them in the liver (19.1%). The percentage of patients with positive estrogen, progesterone, and Her2/neu receptors were not different from negative receptors. Cox regression analysis showed that metastasis had significant effect on death (hazard ratio=2.917). Age 31 ≥ 40 years was the least affected age (hazard ratio=0.034). In conclusion, survival rate of breast cancer patients in Mosul is high due to good management. The early detection of cancer is the best way for survival of the patients, by developing the educational programs.


How to Cite
AL-SAIGH, Taha HT et al. Breast Cancer in Mosul: A Survival Analysis. Al-Mustansiriyah Journal of Pharmaceutical Sciences (AJPS), [S.l.], v. 20, n. 2, p. 31- 36, june 2020. ISSN 1815-0993. Available at: <>. Date accessed: 08 july 2020.